HLNCF
Price
$5.25
Change
+$0.72 (+15.93%)
Updated
Feb 3 closing price
Capitalization
46.6B
Intraday BUY SELL Signals
TAK
Price
$17.43
Change
+$3.35 (+23.79%)
Updated
Feb 3 closing price
Capitalization
55.07B
98 days until earnings call
Intraday BUY SELL Signals
Interact to see
Advertisement

HLNCF vs TAK

Header iconHLNCF vs TAK Comparison
Open Charts HLNCF vs TAKBanner chart's image
HALEON
Price$5.25
Change+$0.72 (+15.93%)
Volume$15.12K
Capitalization46.6B
Takeda Pharmaceutical
Price$17.43
Change+$3.35 (+23.79%)
Volume$4.17M
Capitalization55.07B
HLNCF vs TAK Comparison Chart in %
HLNCF
Daily Signal:
Gain/Loss:
TAK
Daily Signal:
Gain/Loss:
View a ticker or compare two or three
VS
HLNCF vs. TAK commentary
Feb 04, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is HLNCF is a Buy and TAK is a StrongBuy.

Interact to see
Advertisement
COMPARISON
Comparison
Feb 04, 2026
Stock price -- (HLNCF: $5.24 vs. TAK: $17.43)
Brand notoriety: HLNCF and TAK are both not notable
Both companies represent the Pharmaceuticals: Generic industry
Current volume relative to the 65-day Moving Average: HLNCF: 105% vs. TAK: 141%
Market capitalization -- HLNCF: $46.6B vs. TAK: $55.07B
HLNCF [@Pharmaceuticals: Generic] is valued at $46.6B. TAK’s [@Pharmaceuticals: Generic] market capitalization is $55.07B. The market cap for tickers in the [@Pharmaceuticals: Generic] industry ranges from $64.79B to $0. The average market capitalization across the [@Pharmaceuticals: Generic] industry is $4.75B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

HLNCF’s FA Score shows that 1 FA rating(s) are green whileTAK’s FA Score has 2 green FA rating(s).

  • HLNCF’s FA Score: 1 green, 4 red.
  • TAK’s FA Score: 2 green, 3 red.
According to our system of comparison, TAK is a better buy in the long-term than HLNCF.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

HLNCF’s TA Score shows that 5 TA indicator(s) are bullish while TAK’s TA Score has 5 bullish TA indicator(s).

  • HLNCF’s TA Score: 5 bullish, 2 bearish.
  • TAK’s TA Score: 5 bullish, 4 bearish.
According to our system of comparison, HLNCF is a better buy in the short-term than TAK.

Price Growth

HLNCF (@Pharmaceuticals: Generic) experienced а +1.45% price change this week, while TAK (@Pharmaceuticals: Generic) price change was +3.08% for the same time period.

The average weekly price growth across all stocks in the @Pharmaceuticals: Generic industry was -1.83%. For the same industry, the average monthly price growth was -2.35%, and the average quarterly price growth was +12.98%.

Reported Earning Dates

TAK is expected to report earnings on May 13, 2026.

Industries' Descriptions

@Pharmaceuticals: Generic (-1.83% weekly)

A generic drug contains the same chemical substance as a drug that was originally protected by patents. Generic drugs are generally sold at cheaper price points, compared to name-brand pharmaceuticals, after patents for the more expensive drugs lapse. The generic drug industry has created a major market, thanks to the lower pricing. According to the Center for Justice and Democracy at New York Law School, 80 percent of all drugs prescribed are generic, and generic drugs are chosen 94 percent of the time when they are available. But their manufacturers must be able to prove to the FDA that they can be effective substitutes for the original drugs. Some of the major generic drug makers include Zoetis, Inc., Allergan plc and Mylan N.V.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
TAK($55.1B) has a higher market cap than HLNCF($46.6B). TAK has higher P/E ratio than HLNCF: TAK (76.67) vs HLNCF (22.97). TAK YTD gains are higher at: 11.802 vs. HLNCF (4.900). TAK has higher annual earnings (EBITDA): 1.04T vs. HLNCF (2.71B). TAK has more cash in the bank: 740B vs. HLNCF (676M). HLNCF has less debt than TAK: HLNCF (8.45B) vs TAK (4.65T). TAK has higher revenues than HLNCF: TAK (4.42T) vs HLNCF (11B).
HLNCFTAKHLNCF / TAK
Capitalization46.6B55.1B85%
EBITDA2.71B1.04T0%
Gain YTD4.90011.80242%
P/E Ratio22.9776.6730%
Revenue11B4.42T0%
Total Cash676M740B0%
Total Debt8.45B4.65T0%
FUNDAMENTALS RATINGS
TAK: Fundamental Ratings
TAK
OUTLOOK RATING
1..100
64
VALUATION
overvalued / fair valued / undervalued
1..100
8
Undervalued
PROFIT vs RISK RATING
1..100
74
SMR RATING
1..100
89
PRICE GROWTH RATING
1..100
42
P/E GROWTH RATING
1..100
7
SEASONALITY SCORE
1..100
65

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
HLNCFTAK
RSI
ODDS (%)
N/A
Bearish Trend 2 days ago
34%
Stochastic
ODDS (%)
Bearish Trend 2 days ago
58%
Bearish Trend 2 days ago
47%
Momentum
ODDS (%)
Bullish Trend 2 days ago
59%
Bullish Trend 2 days ago
38%
MACD
ODDS (%)
Bullish Trend 2 days ago
79%
Bullish Trend 2 days ago
31%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
64%
Bullish Trend 2 days ago
41%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
66%
Bullish Trend 2 days ago
38%
Advances
ODDS (%)
Bullish Trend 6 days ago
70%
Bullish Trend 3 days ago
44%
Declines
ODDS (%)
Bearish Trend 20 days ago
59%
Bearish Trend 14 days ago
44%
BollingerBands
ODDS (%)
N/A
Bearish Trend 2 days ago
33%
Aroon
ODDS (%)
Bullish Trend 2 days ago
67%
Bullish Trend 2 days ago
45%
View a ticker or compare two or three
Interact to see
Advertisement
HLNCF
Daily Signal:
Gain/Loss:
TAK
Daily Signal:
Gain/Loss:
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
ETFs / NAMEPrice $Chg $Chg %
IJJ138.420.65
+0.47%
iShares S&P Mid-Cap 400 Value ETF
WTMY25.61N/A
N/A
WisdomTree High Income Ldrd Muncpl
GHMS26.24N/A
N/A
Goose Hollow Multi-Strategy Income ETF
IIM12.39-0.01
-0.08%
INVESCO VALUE Municipal Income TRUST
FBY12.76-0.22
-1.69%
YieldMax META Option Income Strategy ETF

HLNCF and

Correlation & Price change

A.I.dvisor indicates that over the last year, HLNCF has been loosely correlated with HLN. These tickers have moved in lockstep 49% of the time. This A.I.-generated data suggests there is some statistical probability that if HLNCF jumps, then HLN could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To HLNCF
1D Price
Change %
HLNCF100%
+0.87%
HLN - HLNCF
49%
Loosely correlated
-0.66%
SGIOF - HLNCF
21%
Poorly correlated
+18.18%
EAPIF - HLNCF
11%
Poorly correlated
N/A
ZTS - HLNCF
10%
Poorly correlated
-2.02%
TAK - HLNCF
10%
Poorly correlated
-0.34%
More

TAK and

Correlation & Price change

A.I.dvisor indicates that over the last year, TAK has been loosely correlated with SGIOY. These tickers have moved in lockstep 41% of the time. This A.I.-generated data suggests there is some statistical probability that if TAK jumps, then SGIOY could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To TAK
1D Price
Change %
TAK100%
-0.34%
SGIOY - TAK
41%
Loosely correlated
+2.07%
HLN - TAK
36%
Loosely correlated
-0.66%
ESAIY - TAK
35%
Loosely correlated
-1.84%
BNXTF - TAK
32%
Poorly correlated
N/A
ZTS - TAK
30%
Poorly correlated
-2.02%
More